NCT00406302 - Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Carcinoma, Non-small-cell Lung

Interventions

DRUG

Docetaxel

75mg/m², day 1,22

DRUG

oxaliplatin

40mg/m², d1,2,22,23

DRUG

cetuximab

400mg/m² (day1), 250mg/m² (day 8,15,22,29,36)

PROCEDURE

surgery

28 days after end of induction chemotherapy

Trial Locations (7)

University Hospital, Internal Medicine, Innsbruck

Hosptial Kufstein, Kufstein

Hospital Natters, Natters

Hospital Zams, Zams

Prim. Dr. Bolitschek, Linz

Prim. Dr. H. Schinko, Linz

OA Dr. Rainer Kolb, Wels